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Purpose: To assess diagnostic performance and interreader 
agreement of tumor-to-sinus distance measurements and 
visual assessment of renal sinus fat invasion at T2-weight-
ed magnetic resonance (MR) imaging as predictors of 
muscular venous branch invasion (MVBI) in patients with 
renal cell carcinoma (RCC).
Materials and 
Methods:
The institutional review board approved this retrospective 
study and waived the informed consent requirement. The 
study was HIPAA compliant. A total of 186 consecutive 
patients underwent preoperative 1.5-T MR imaging; 188 
RCCs were identified. Blinded to histopathologic informa-
tion, two readers independently measured the tumor-to-
sinus distance and assessed renal sinus fat invasion on 
transverse and coronal T2-weighted MR images. Inter-
reader agreement (intraclass correlation coefficient, Co-
hen k) and performance characteristics of imaging tests 
were calculated. Histopathologic findings served as the 
standard of reference.
Results: Histopathologic findings indicated MVBI in 35% (66 of 
188) of tumors. At imaging, all tumors with MVBI had 
a tumor-to-sinus distance of 0 mm. All tumors with re-
nal sinus fat invasion at imaging had MVBI. Sensitivity 
and specificity for the detection of renal sinus fat invasion 
were 100% (95% confidence interval [CI]: 92%, 100%) 
and 94% (95% CI: 89%, 98%). In the absence of renal si-
nus fat invasion at imaging, a tumor-to-sinus distance of 0 
mm was associated with MVBI in 21% (18 of 86) of cases. 
Interreader agreement for quantitative (intraclass correla-
tion coefficient = 0.92; 95% CI: 0.89, 0.94) and qualitative 
(k = 0.89; 95% CI: 0.81, 0.96) assessments was excellent.
Conclusion: Tumor-to-sinus distance measurements and the assess-
ment of renal sinus fat invasion at T2-weighted MR im-
aging can be used reliably to rule out MVBI in patients 
with RCC.
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period from January 2005 to July 2011; 
(b) preoperative 1.5-T MR imaging of 
the abdomen, including transverse and 
coronal T2-weighted sequences, per-
formed within 90 days before surgery 
(median time, 28.5 days; range, 1–90 
days) and available in Digital Imaging 
and Communications in Medicine for-
mat through the hospital’s picture ar-
chiving and communication system; (c) 
the use of surgical pathologic examina-
tion results to confirm the diagnosis of 
RCC, establish Fuhrman grade in case 
of clear cell carcinoma, and confirm the 
presence or absence of MVBI by tumor.
As shown in the patient selection 
flowchart in Figure 1, 186 patients were 
eligible for the study. The patients’ de-
mographic and tumor characteristics 
are summarized in Table 1.
MR Imaging Technique
MR imaging studies were performed 
with 1.5-T units (Signa Excite or Gene-
sis Signa, GE Medical Systems, Milwau-
kee, Wis [n = 164]; Avanto, Espree, 
or Symphony, Siemens Medical Solu-
tions, Forchheim, Germany [n = 23]; 
or Infineon, Philips Medical Systems, 
Eindhoven, the Netherlands [n = 1]). 
Relevant parameters regarding the 
transverse and coronal T2-weighted se-
quences are summarized in Table 2.
MR Image Analysis
Without access to histopathologic in-
formation, two radiologists with more 
the presence of MVBI preoperatively in 
patients with RCC would be of consid-
erable clinical value.
To date, to our knowledge, there 
have been no studies to investigate the 
role of cross-sectional imaging in the as-
sessment of MVBI. Although magnetic 
resonance (MR) imaging is useful for 
staging RCC (10), its spatial resolution 
may not be sufficient to allow direct 
visualization of the muscular venous 
branches of the renal vein, some of 
which have calibers of less than 2 mm 
(5). However, we hypothesize that the 
shortest distance between the renal tu-
mor and the adipose tissue of the renal 
sinus, as well as evidence of renal sinus 
fat invasion at imaging, may serve as 
surrogate predictors of MVBI in patients 
with RCC.
Thus, the objective of our study was 
to assess diagnostic performance char-
acteristics and interreader agreement 
of tumor-to-sinus distance measure-
ments and the qualitative assessment 
of renal sinus fat invasion on transverse 
and coronal T2-weighted MR images 
as predictors of MVBI in patients with 
RCC, with use of histopathologic exam-
ination as the standard of reference.
Materials and Methods
Patients
The institutional review board ap-
proved this retrospective study and 
waived the informed consent require-
ment. The study was compliant with 
the Health Insurance Portability and 
Accountability Act.
The inclusion criteria for our study 
were (a) total or partial nephrectomy 
performed at our institution during the 
Invasion of the renal sinus fat in patients with renal cell carcinoma (RCC) is an important surgical path-
ologic finding that affects tumor stag-
ing and patient prognosis (1–3). How-
ever, before invading the renal sinus 
fat, RCCs extend into muscular venous 
branches of the renal vein, which then 
serve as the main pathways for renal si-
nus fat invasion (4–7). Muscular venous 
branches of the renal vein emerge from 
interlobar veins at the interface be-
tween the renal parenchyma and renal 
sinus and continue their course through 
the adipose tissue of the renal sinus to 
form the main renal vein after three or 
four anastomoses (5).
In patients with RCC, muscular ve-
nous branch invasion (MVBI) is consid-
ered a key criterion for tumor staging 
and an important adverse prognostic 
factor regarding recurrence-free and 
overall survival (8,9). Moreover, the 
effect of MVBI on patient prognosis 
is comparable with that of main renal 
vein invasion or inferior vena cava in-
vasion (9). Thus, the ability to assess 
Implication for Patient Care
 n Tumor-to-sinus distance measure-
ments and visual assessment of 
renal sinus fat invasion at MR 
imaging are useful surrogate 
markers for assessing MVBI, a 
TNM stage–defining histopatho-
logic finding that substantially 
affects the prognosis and treat-
ment of patients with RCC.
Advances in Knowledge
 n A tumor-to-sinus distance greater 
than 0 mm at imaging was used 
to rule out muscular venous 
branch invasion (MVBI) in renal 
cell carcinoma (RCC) in 100% 
(49 of 49) of cases.
 n When renal sinus fat invasion 
was present at imaging, MVBI 
was identified in 100% (48 of 48) 
of cases at histopathologic 
examination.
 n When renal sinus fat invasion 
was absent at imaging and the 
tumor-to-sinus distance was 0 
mm, MVBI was identified in 21% 
(18 of 86) of cases at histopatho-
logic examination.
 n Interreader agreement was excel-
lent for tumor-to-sinus distance 
measurements (intraclass corre-
lation coefficient = 0.92; 95% 
confidence interval [CI]: 0.89, 
0.94) and the visual assessment 
of renal sinus fat invasion (k = 
0.89; 95% CI: 0.81, 0.96).
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classification system by a genitourinary 
pathologist (S.T.) with more than 20 
years of experience (12).
Statistical Methods
To assess interreader agreement re-
garding the tumor-to-sinus distance 
measurements, we calculated the in-
traclass correlation coefficient for 
absolute agreement, including the 
corresponding 95% confidence inter-
vals (CIs) (13). To assess interreader 
agreement regarding the assessment 
of renal sinus fat invasion, we calcu-
lated Cohen k values, including the 
corresponding 95% CIs.
A Pearson correlation coefficient 
was used to correlate tumor-to-sinus 
distance measurements obtained from 
the transverse and coronal imaging 
planes. A Spearman rank correlation 
closest to the adipose tissue of the 
renal sinus and the interface between 
the renal parenchyma and renal sinus, 
henceforth referred to as the tumor-
to-sinus distance. The shortest tumor-
to-sinus distance in the transverse 
plane and the shortest tumor-to-sinus 
distance in the coronal plane were re-
corded (Figs 2, 3).
Standard of Reference
Original surgical histopathologic reports 
served as the standard of reference for 
the presence or absence of MVBI, as 
well as the presence or absence of re-
nal sinus fat invasion. At surgical his-
topathologic examination, tumor types 
were classified as clear cell, papillary, 
chromophobe, or unclassified RCC. In 
addition, each clear cell carcinoma was 
classified according to the Fuhrman 
than 5 (C.A.K. [reader 1]) and more 
than 3 (P.L.D.P. [reader 2]) years of 
experience interpreting genitourinary 
imaging studies independently re-
viewed all MR images by using picture 
archiving and communication system 
software (Centricity; GE Medical 
Systems). First, both readers qualita-
tively assessed the transverse and co-
ronal T2-weighted MR images for the 
presence or absence of renal sinus fat 
invasion by tumor. Then, each reader 
measured the shortest distance in mil-
limeters between the tumor margin 
Figure 1
Figure 1: Flowchart of patient 
selection. DICOM = Digital 
Imaging and Communications in 
Medicine, MRI = MR imaging.
Table 1
Patient and Tumor Characteristics
Characteristic Datum
Sex
 Male 67 (124/186)
 Female 33 (62/186)
Age (y)*
 Male 59 (34–83)
 Female 56 (17–84)
Type of RCC†
 Clear cell 76 (143/188)
 Chromophobe 12 (22/188)
 Papillary 11 (21/188)
 Unclassified 1 (2/188)
Tumor size (cm)*† 5.3 (1.3–23.0)
Tumor side†
 Right 51 (96/188)
 Left 49 (92/188)
Tumor stage of RCC†
 pT1a 35.6 (67/188)
 pT1b 14.4 (27/188)
 pT2a 5.3 (10/188)
 pT2b 5.3 (10/188)
 pT3a 12.2 (23/188)
 pT3b 26.6 (50/188)
 pT4 0.5 (1/188)
Fuhrman nuclear grade‡
 1 2 (3/143)
 2 43 (62/143)
 3 37 (53/143)
 4 17 (25/143)
Note.—Except where otherwise indicated, data are 
percentages, with raw data in parentheses. Percentages 
may not add up to 100% owing to rounding.
* Data are medians, with ranges in parentheses.
† In terms of the histopathologic data, tumor stage was 
determined according to the sixth edition of the 
American Joint Committee on Cancer cancer staging 
manual (11) for all tumor types except angiomyolipoma.
‡ For clear cell RCCs only.
Table 2
MR Imaging Parameters
Parameter Transverse Plane Coronal Plane
Repetition time (msec) 921–4300 850–6000
Echo time (msec) 80.9–200 64.0–122
Field of view Fitted to patient Fitted to patient
Section thickness (mm) 4–8 4–8
No. of phase-encoding steps 176–384 192–512
No. of frequency steps 256–512 256–512
No. of signals acquired 0.5–3 0.5–3
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significant differences in the frequency 
of MVBI between low-grade and high-
grade clear cell carcinoma.
Sensitivity, specificity, negative pre-
dictive value, and positive predictive 
value for the identification of MVBI in 
case the tumor-to-sinus distance was 
0 mm in patients without evidence of 
renal sinus fat invasion at imaging were 
assessed by using x2 tests of contin-
gency. Sensitivity, specificity, negative 
predictive value, and positive predictive 
value for the identification of renal si-
nus fat invasion at imaging were also as-
sessed by using x2 tests of contingency.
Two-sided P values of less than .05 
were considered to indicate statistically 
significant differences. All statistical 
analyses were performed by using com-
mercially available software (SPSS, ver-
sion 19; IBM, Armonk, NY).
Results
Histopathologic Findings
In the 186 patients, a total of 188 
RCCs were detected by means of his-
topathologic examination (Table 1). 
Two patients had more than one car-
cinoma (one had two clear cell carci-
nomas in the same kidney, and one 
had one clear cell and one chromo-
phobe carcinoma in the same kidney). 
MVBI was present in 35.1% (66 of 
188) of RCCs. MVBI was more com-
mon in clear cell (81.8% [54 of 66]) 
than in chromophobe (16.7% [11 of 
66]) and unclassified (1.5% [one of 
66]) RCCs. Renal sinus fat invasion 
was present in 21.3% (40 of 188) of 
carcinomas and was more common in 
clear cell (72.5% [29 of 40]) than in 
chromophobe (25% [10 of 40]) and 
unclassified (2.5% [one of 40]) RCCs.
All patients with renal sinus fat in-
vasion had MVBI (21.3% [40 of 188]). 
However, in 39% (26 of 66) of cases 
with MVBI, renal sinus fat invasion was 
absent. RCCs were significantly larger 
in cases with MVBI (median, 9.0 cm; 
range, 3.2–20.5 cm) than in cases with-
out MVBI (median, 3.6 cm; range, 1.3–
23.0 cm; P , .001). The presence of 
MVBI was associated with high-grade 
clear cell carcinoma (r = 0.4, P , .01); 
Kruskal-Wallis test was used to test 
for significant differences in histo-
pathologic tumor size between tumors 
with MVBI and tumors without MVBI, 
significant differences in tumor-to-
sinus distance between tumors with 
MVBI and tumors without MVBI, and 
coefficient was used to correlate be-
tween the presence of MVBI and 
Fuhrman grades of clear cell car-
cinoma, which were consolidated 
into low grade (ie, grades 1 and 2) 
and high grade (ie, grades 3 and 4), 
as previously suggested (14). The 
Figure 3
Figure 3: A, Transverse T2-weighted 
(repetition time msec/echo time msec, 
2400/100) MR image in 64-year-old man 
with clear cell carcinoma shows renal sinus 
invasion by tumor. B, Transverse T2-weighted 
(2400/99) MR image in 63-year-old man 
with clear cell carcinoma shows the renal 
tumor abutting the renal sinus. C, Transverse 
T2-weighted (2300/100) MR image in 
48-year-old man with papillary RCC shows 
that the tumor is separated from the renal 
sinus by normal kidney parenchyma; arrow 
= tumor-to-sinus distance. Dashed lines = 
tumor circumferences.
Figure 2
Figure 2: Illustration shows examples in which RCC, A, extensively invades the renal sinus, B, abuts the 
renal sinus, C, abuts the renal sinus and invades muscular venous branches of the renal vein, and, D, is 
separate from the renal sinus.
458 radiology.rsna.org n Radiology: Volume 267: Number 2—May 2013
GENITOURINARY IMAGING: Assessing Muscular Venous Branch Invasion in Renal Cell Carcinoma at MR Imaging Karlo et al
evidence of renal sinus fat invasion at 
imaging and a tumor-to-sinus distance 
of 0 mm. Third, in patients without 
evidence of renal sinus fat invasion at 
imaging, a tumor-to-sinus distance of 0 
mm had sensitivity and specificity for 
the detection of MVBI of 100% and 
42%, respectively.
Although none of the patients with 
a tumor-to-sinus distance greater than 
0 mm had MVBI, our data indicate that 
the shorter the tumor-to-sinus distance, 
the higher the likelihood of MVBI. Thus, 
the tumor-to-sinus distance should be 
measured on both the transverse and 
coronal imaging planes, and the shorter 
one should be used. In our study, mea-
surements derived from the transverse 
imaging plane were shorter than the 
ones derived from the coronal plane in 
86% (157 of 183) of cases.
MVBI was found predominantly in 
clear cell carcinomas, which is not sur-
prising because clear cell carcinomas 
are the most aggressive type of renal 
cortical tumor (14). However, MVBI 
was not found exclusively in clear 
cell carcinomas but also appeared in 
chromophobe and unclassified carci-
nomas. In our study, all patients with 
evidence of renal sinus fat invasion at 
imaging had MVBI at histopathologic 
examination. This finding supports 
those of a prior histopathologic study 
(5) in which the investigators found 
that renal sinus fat invasion always oc-
curred after MVBI.
Our results suggest that the as-
sessment of a renal tumor’s rela-
tionship to the renal sinus fat could 
improve the identification of patients 
with and—more importantly—those 
without MVBI. According to our find-
ings, 21% (18 of 86) of patients in 
whom the renal tumor was in contact 
with the renal sinus (ie, the tumor-
to-sinus distance was 0 mm) and 
who usually would be assigned a tu-
mor stage of T2, in fact had stage 
T3 disease owing to the presence of 
MVBI. In addition, the distance be-
tween a renal tumor and the renal si-
nus fat could affect surgical planning. 
Thus, surgeons should be aware of the 
fact that renal tumors that are in di-
rect contact with the renal sinus fat at 
measurements obtained from the 
transverse and coronal imaging planes 
for both readers (reader 1, r = 0.63; 
reader 2, r = 0.53; both, P , .001). For 
the tumor-to-sinus distance analysis, 
we used the shortest tumor-to-sinus 
distance measurement for each tumor 
and for each reader. Thus, we used the 
tumor-to-sinus distance measurements 
obtained from the transverse imaging 
plane in 86% (157 of 183) of cases 
and the one obtained from the coronal 
imaging plane in 14% (26 of 183) of 
cases. The tumor-to-sinus distance was 
significantly shorter in cases with MVBI 
(both readers: median, 0 mm; range, 
0–0 mm) than in cases without MVBI 
(reader 1: median, 0 mm, range, 0–16 
mm; reader 2: median, 0 mm, range, 
0–13 mm; P , .001).
In all cases with a tumor-to-sinus 
distance greater than 0 mm (n = 49), 
MVBI was absent at histopathologic ex-
amination. In all cases with evidence of 
renal sinus fat invasion at imaging (n = 
48), MVBI was present at histopatho-
logic examination. MVBI was present in 
21% (18 of 86) of cases in which renal 
sinus fat invasion was absent at imag-
ing and the tumor-to-sinus distance was 
0 mm. In patients without evidence of 
renal sinus fat invasion at imaging (n 
= 135), a tumor-to-sinus distance of 0 
mm had a sensitivity, specificity, nega-
tive predictive value, and positive pre-
dictive value for the detection of MVBI 
of 100% (95% CI: 81%, 100%), 42% 
(95% CI: 33%, 51%), 100% (95% CI: 
93%, 100%), and 21% (95% CI: 13%, 
31%), respectively (18 true-positive, 49 
true-negative, 68 false-positive, and no 
false-negative findings).
Discussion
In patients with RCC, MVBI is an im-
portant prognostic parameter regard-
ing recurrence-free and overall survival 
and a TNM stage–defining criterion. 
Our study yielded three key findings. 
First, all patients with evidence of re-
nal sinus fat invasion at T2-weighted 
MR imaging had MVBI at histopatho-
logic examination. Second, MVBI was 
found at histopathologic examination in 
21% (18 of 86) of patients who had no 
MVBI was identified significantly more 
often in high-grade (78% [43 of 55]) 
than in low-grade (22% [12 of 55], P , 
.001) clear cell carcinomas.
Interreader Agreement
Interreader agreement regarding all 
tumor-to-sinus distance measurements 
(intraclass correlation coefficient = 
0.92; 95% CI: 0.89, 0.94) was excel-
lent. Interreader agreement regarding 
the assessment of renal sinus fat inva-
sion (k = 0.89; 95% CI: 0.81, 0.96) was 
also excellent.
Renal Sinus Fat Invasion
At imaging, both readers detected re-
nal sinus fat invasion in 25.5% (48 of 
188) of cases. All cases that were pos-
itive for renal sinus fat invasion at his-
topathologic examination (40 of 188) 
were identified correctly at imaging by 
both readers. For both readers, sen-
sitivity, specificity, negative predictive 
value, and positive predictive value for 
the detection of renal sinus fat invasion 
at imaging were 100% (95% CI: 91%, 
100%), 94% (95% CI: 89%, 97%), 
100% (95% CI: 97%, 100%), and 83% 
(95% CI: 70%, 92%), respectively (40 
true-positive, eight false-positive, 135 
true-negative, and no false-negative 
findings).
Tumor-to-Sinus Distance
At imaging, both readers measured the 
tumor-to-sinus distance on transverse 
T2-weighted MR images in 91.5% (172 
of 188) of tumors and on coronal T2-
weighted MR images in 84.6% (159 of 
188) of tumors. In 2.7% (five of 188) 
of tumors, both readers determined 
that the tumor-to-sinus distance mea-
surement was possible on neither the 
transverse nor the coronal MR images 
because the renal tumor was located 
on either the very anterior or the very 
posterior aspect of the upper or lower 
kidney pole and, therefore, the tumor 
and the renal sinus were never visible 
on the same image. These five tumors 
were excluded from further analysis, 
which thus consisted of 97% (183 of 
188) of tumors.
A moderate positive correlation was 
found between tumor-to-sinus distance 
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T2-weighted MR imaging have a sub-
stantially higher risk of causing MVBI 
than do tumors separated from the 
renal sinus fat. Hence, the results of 
this study could influence a surgeon’s 
decision between partial and radical 
nephrectomy.
Our study had the following limi-
tation. Although contrast material–en-
hanced MR imaging was available in 
most cases, we did not incorporate it 
in our analysis, even though it may be 
more accurate than T2-weighted MR 
imaging for outlining tumor margins. 
We made this decision in part because 
we considered it important to measure 
the tumor-to-sinus distance in two im-
aging planes (transverse and coronal) 
because of the kidney’s anatomy and 
alignment in the retroperitoneal space, 
but contrast-enhanced MR images were 
available in only the transverse plane 
in most patients. In addition, we con-
sidered T2-weighted MR images more 
useful for illustrating relevant anatomic 
details of the renal hilum.
In summary, the relationship be-
tween a renal tumor and the renal si-
nus fat at T2-weighted MR imaging was 
associated closely with the presence or 
absence of MVBI at histopathologic ex-
amination. Although MVBI was identi-
fied in all tumors exhibiting renal sinus 
fat invasion at imaging, it also was found 
in one-fifth of tumors that were in con-
tact with—but not invading—the renal 
sinus fat at imaging. More importantly, 
a tumor-to-sinus distance of more than 
0 mm could be used to rule out MVBI. 
In conclusion, tumor-to-sinus distance 
measurements and the qualitative as-
sessment of renal sinus fat invasion at 
T2-weighted imaging provide useful sur-
rogate markers to rule out MVBI reliably 
in patients with RCC.
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